Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name C1 esterase inhibitor (recombinant)
Drug ID BADD_D00327
Description C1 Esterase Inhibitor (Recombinant) is a recombinant analogue of endogenous complement component-1 esterase inhibitor (rhC1INH), purified from the milk of transgenic rabbits. The primary function of endogenous C1INH is to regulate the activation of the complement and contact system pathways. It does this through inhibition of several target proteases within these pathways including activated C1s, kallikrein, factor XIIa and factor XIa. C1 esterase inhibitor has also been shown to inhibit the action of thrombin within the coagulation pathway, and tPA and plasmin within the fibrinolytic pathway. Deficiency of C1-inhibitor allows for increased plasma kallikrein activation and subsequent production of bradykinin. Additionally, C4 and C2 cleavage occurs resulting in auto-activation of the complement system. Down-stream effects of the lack of enzyme inhibition by C1 esterase inhibitor results in swelling due to leakage of fluid from blood vessels into connective tissue and consequently the presentation of hereditary angioedema (HAE). Marketed as the product Ruconest (FDA), this drug is indicated for the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults. Intravenous replacement of C1 esterase inhibitor results in reversal of acute symptoms of HAE.
Indications and Usage For the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults.
Marketing Status Not Available
ATC Code B06AC04
DrugBank ID DB09228
KEGG ID D10845
MeSH ID C571093
PubChem ID Not Available
TTD Drug ID D0Z7ZM
NDC Product Code Not Available
Synonyms conestat alfa | conestat alpha | recombinant human C1-inhibitor rabbit milk derived | complement C1 esterase inhibitor | constat alfa | Ruconest | Rhucin
Chemical Information
Molecular Formula Not Available
CAS Registry Number 80295-38-1
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Angioedema23.04.01.001; 10.01.05.009--Not Available
Back pain15.03.04.005--
C-reactive protein increased13.09.01.007--Not Available
Diarrhoea07.02.01.001--
Erythema marginatum23.03.08.008; 11.07.01.015--Not Available
Fibrin D dimer increased13.01.02.036--Not Available
Headache17.14.01.001--
Lipoma16.18.01.001; 15.09.01.001--Not Available
Nausea07.01.07.001--
Rash23.03.13.001--Not Available
Sneezing22.02.05.011--
Vertigo17.02.12.002; 04.04.01.003--
Skin burning sensation23.03.03.021; 17.02.06.009--Not Available
Procedural headache17.14.01.016; 12.02.04.007--Not Available
The 1th Page    1    Total 1 Pages